Medical Advisory

Medical Advisory: ALTUVIIIO lot #EY0330 of 2000 IU nominal vial potency was erroneously labeled with an actual potency of 2132 IU/mg on the finished product and cartons instead of the correct value of 1811 IU/vial.

Takeda notifies the U.S. Food and Drug Administration (FDA) of reports of plastic particles originating near the luer port of the BAXJECT II device.

Advisory #428 notes these medications are administered in a hospital setting only by trained healthcare professionals.

Ferring has extended the recall of Stimate to the consumer level.

CSL Behring and Ferring Pharmaceuticals have announced a recall of lots of Stimate®.